These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17332908)

  • 41. [Vancomycin and high-level aminoglycoside resistant Enterococcus carriage and the risk factors related to resistance in hospitalized patients].
    Yildirim M; Sencan I; Ozdemir D; Oksüz S; Yilmaz Z; Sahin I
    Mikrobiyol Bul; 2007 Apr; 41(2):271-7. PubMed ID: 17682714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-level gentamicin resistance and vancomycin resistance in clinical isolates of enterococci in a tertiary care hospital in eastern Nepal.
    Nepal HP; Khanal B; Acharya A; Gyawali N; Jha PK; Paudel R
    Nepal Med Coll J; 2012 Mar; 14(1):60-3. PubMed ID: 23441498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro activity of dalbavancin against enterococci isolates from wild animals, pets, poultry and humans in Portugal.
    Poeta P; Radhouani H; Sargo R; Igrejas G
    J Basic Microbiol; 2008 Dec; 48(6):526-8. PubMed ID: 18798175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
    Sahuquillo Arce JM; Colombo Gainza E; Gil Brusola A; Ortiz Estévez R; Cantón E; Gobernado M
    Rev Esp Quimioter; 2006 Sep; 19(3):252-7. PubMed ID: 17099793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro antimicrobial effect of cefazolin and cefotaxime combined with minocycline against Vibrio cholerae non-O1 non-O139.
    Su BA; Tang HJ; Wang YY; Liu YC; Ko WC; Liu CY; Chuang YC;
    J Microbiol Immunol Infect; 2005 Dec; 38(6):425-9. PubMed ID: 16341343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emergence of resistance to chloramphenicol among vancomycin-resistant enterococcal (VRE) bloodstream isolates.
    Lautenbach E; Gould CV; LaRosa LA; Marr AM; Nachamkin I; Bilker WB; Fishman NO
    Int J Antimicrob Agents; 2004 Feb; 23(2):200-3. PubMed ID: 15013047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New selective and differential chromogenic agar medium, chromID VRE, for screening vancomycin-resistant Enterococcus species.
    Kuch A; Stefaniuk E; Ozorowski T; Hryniewicz W
    J Microbiol Methods; 2009 Apr; 77(1):124-6. PubMed ID: 19167435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antimicrobial resistance of enterococcal blood isolates at a pediatric care hospital in India.
    Kapoor L; Randhawa VS; Deb M
    Jpn J Infect Dis; 2005 Apr; 58(2):101-3. PubMed ID: 15858289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium].
    Pérez Salmerón J; Martínez García F; Roldán Conesa D; Lorente Salinas I; López Fornás F; Ruiz Gómez J; Gómez Gómez J; Segovia Hernández M; Valdés Chávarri M
    Rev Esp Quimioter; 2006 Sep; 19(3):258-66. PubMed ID: 17099794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Daptomycin-reversible rifampicin resistance in vancomycin-resistant Enterococcus faecium.
    Rand KH; Houck HJ; Silverman JA
    J Antimicrob Chemother; 2007 May; 59(5):1017-20. PubMed ID: 17369277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibiotic and disinfectant susceptibility profiles of vancomycin-resistant Enterococcus faecium (VRE) isolated from community wastewater in Texas.
    Beier RC; Duke SE; Ziprin RL; Harvey RB; Hume ME; Poole TL; Scott HM; Highfield LD; Alali WQ; Andrews K; Anderson RC; Nisbet DJ
    Bull Environ Contam Toxicol; 2008 Mar; 80(3):188-94. PubMed ID: 18193143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Virulence and antimicrobial resistance in clinical Enterococcus faecium.
    Billström H; Lund B; Sullivan A; Nord CE
    Int J Antimicrob Agents; 2008 Nov; 32(5):374-7. PubMed ID: 18715765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bactericidal activities of disinfectants against vancomycin-resistant enterococci.
    Sakagami Y; Kajimura K
    J Hosp Infect; 2002 Feb; 50(2):140-4. PubMed ID: 11846542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer.
    Matar MJ; Tarrand J; Raad I; Rolston KV
    Am J Infect Control; 2006 Oct; 34(8):534-6. PubMed ID: 17015161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergy of flavone with vancomycin and oxacillin against vancomycin-intermediate Staphyloccus aureus.
    Bakar NS; Zin NM; Basri DF
    Pak J Pharm Sci; 2012 Jul; 25(3):633-8. PubMed ID: 22713953
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
    Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
    Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Investigation of phenotypic and genotypic characteristics of vancomycin-resistant Enterococcus faecium isolates].
    Aktaş Z; Diyarbakirli P; Bal C; Gürler N; Keser M; Somer A; Salman N
    Mikrobiyol Bul; 2007 Jul; 41(3):347-56. PubMed ID: 17933244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    Rose WE; Poppens PT
    J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations.
    Hayden MK; Koenig GI; Trenholme GM
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1225-9. PubMed ID: 8092818
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibacterial activity of sophoraflavanone G isolated from the roots of Sophora flavescens.
    Cha JD; Jeong MR; Jeong SI; Lee KY
    J Microbiol Biotechnol; 2007 May; 17(5):858-64. PubMed ID: 18051310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.